InVivo Therapeutics Hldgs Corp (fka NVIVQ)

[veni vidi vici]

Seel,

I see it differently based on my DD. You replied "Road Show?" - IMO, absolutely: So far Frank Reynolds has clearly overpromised and underdelivered. He is always on the road touting the promising results from the animal studies but yet has anything to actually show for in terms of getting the required FDA approval done to be able to start human clinical trials. If you follow the company, you will see they were saying already in 2009 that they were expecting to have the approval soon.

You say "last chances to get in cheap" - This stock traded in the mid 60 cents last October and has gone up on a generally thin volume to reach the current levels on pure expectation - NOT execution. As far as I see, its way overhyped.